摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

rac-(6Ξ)-6,14-epoxy-17-methyl-7,8-seco-morphinan-3-ol

中文名称
——
中文别名
——
英文名称
rac-(6Ξ)-6,14-epoxy-17-methyl-7,8-seco-morphinan-3-ol
英文别名
(1R,9R,10S)-10,12,16-trimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol
<i>rac</i>-(6Ξ)-6,14-epoxy-17-methyl-7,8-seco-morphinan-3-ol化学式
CAS
——
化学式
C17H23NO2
mdl
——
分子量
273.375
InChiKey
KOIWWLNSZWPHPI-OMILXILMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    20
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    32.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    rac-3-methoxy-17-methyl-7,8-seco-morphin-6-en-14-ol 在 氢溴酸 作用下, 反应 0.17h, 生成 rac-(6Ξ)-6,14-epoxy-17-methyl-7,8-seco-morphinan-3-ol
    参考文献:
    名称:
    5-Allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9.beta.-dihydroxy-6,7-benzomorphans
    摘要:
    5-Allyl-2'-methoxy-2-methyl-9-oxo-6,7-benzomorphan methiodide (1) has been converted in a selective two-step process to the corresponding 9beta-hydroxy intermediates 4 and 6, which in turn were transformed via modified von Braun demethylation-acylation to the amides 11 and 21, respectively. These were reduced and demethylated to give a series of 5-allyl-2',9beta-dihydroxy-2-substituted 6,7-benzomorphans 13 and 23, some of which have been found to be highly potent narcotic antagonists and/or analgesics. The resolution of the most interesting compounds (23a and 23b) and pharmacological properties of the optical isomers are also described. Reduction of the double bond in 13 and 23 to give 14 and 24, with one exception, did not appreciably alter pharmacological profiles, while cyclization to the tetrahydrofuranobenzomorphans 25 substantially reduced the level of activities.
    DOI:
    10.1021/jm00215a012
点击查看最新优质反应信息

文献信息

  • 5-Allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9.beta.-dihydroxy-6,7-benzomorphans
    作者:Michel Saucier、Jean Paul Daris、Yvon Lambert、Ivo Monkovic、Anthony W. Pircio
    DOI:10.1021/jm00215a012
    日期:1977.5
    5-Allyl-2'-methoxy-2-methyl-9-oxo-6,7-benzomorphan methiodide (1) has been converted in a selective two-step process to the corresponding 9beta-hydroxy intermediates 4 and 6, which in turn were transformed via modified von Braun demethylation-acylation to the amides 11 and 21, respectively. These were reduced and demethylated to give a series of 5-allyl-2',9beta-dihydroxy-2-substituted 6,7-benzomorphans 13 and 23, some of which have been found to be highly potent narcotic antagonists and/or analgesics. The resolution of the most interesting compounds (23a and 23b) and pharmacological properties of the optical isomers are also described. Reduction of the double bond in 13 and 23 to give 14 and 24, with one exception, did not appreciably alter pharmacological profiles, while cyclization to the tetrahydrofuranobenzomorphans 25 substantially reduced the level of activities.
查看更多

同类化合物

普罗啡烷 (9R,10R)-15-(环丙基甲基)-10-甲基-11-氧杂-17-氮杂四环[7.5.3.01,10.0(2,7)]十七-2,4,6-三烯-4-醇 3-methoxy-14β-hydroxy-6-oxamorphinan (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indole (+)-14β-Hydroxy-3-methoxy-17-methyl-6-oxamorphinan N-Propargyl-3-methoxy-14β-methyl-8-oxamorphinan N-Propargyl-3-hydroxy-14β-methyl-8-oxamorphinan NS 28 17-cyclopropylmethyl-7,14α-epoxy-7,14-seco-8-nor-morphinan-3-ol 17-cyclopropylmethyl-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-phenyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one NS22 (1S,5R,13R,14R,17S)-4-methyl-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-trien-10-ol KNT-63 (1R,9R,10S,13R)-18-(cyclopropylmethyl)-4-hydroxy-19-oxa-18-azapentacyclo[7.6.3.1^{10,13}.0^{1,10}.0^{2,7}]nonadeca-2(7),3,5-trien-14-one (1S,9R,10R)-17-(cyclopropylmethyl)-11-hydroxy-4-methoxy-12-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one 17-cyclopropylmethyl-6α,14-epoxy-4,5α-epoxy-3-benzyloxymorphinan Proxorphan tartrate (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one (4bR,8R,8aS,9aS,11aS,11bR)-7-allyl-11-benzyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-methyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-isobutyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (1S,5R,13R,14R,17S)-4-(cyclopropylmethyl)-10-methoxy-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-triene (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-(cyclopropylmethyl)-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one 3-methoxy-10α,17-dimethyl-6-oxamorphinan 3-methoxy-17-methyl-10-methylene-6-oxamorphinan rac-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (1R,9S,10S)-17-(cyclopropylmethyl)-13-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10R)-10,17-dimethyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10S)-17-(cyclopropylmethyl)-10-methyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol 16-(Cyclopropylmethyl)-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 3-Hydroxy-17-methyl-8-oxamorphinan 12,16-Dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol rac-(6Ξ)-6,14β-epoxy-17-methyl-7,14-seco-8-nor-morphinane (1R,9R,10S)-16-cyclobutyl-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 1-[(1R,9R,10S)-10,16-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2,4,6-trien-12-yl]-N,N-dimethylmethanamine;hydrochloride (8S)-6-benzyl-21-(cyclopropylmethyl)-15-hydroxy-11,13,25-trioxa-6,21-diazahexacyclo[12.9.1.12,8.01,9.02,20.018,24]pentacosa-14,16,18(24)-trien-7-one (3S)-5,20-bis(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (3S)-5-benzyl-20-(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-16-ol [(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone [(3S)-20-(cyclopropylmethyl)-5-(4,6-dimethyl-1,2-dihydropyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-yl] trifluoromethanesulfonate 3-[(3S)-20-(cyclopropylmethyl)-15-methoxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-triene-5-carbonyl]benzonitrile [(3S)-20-(cyclopropylmethyl)-15-hydroxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-5-yl]-(2-fluorophenyl)methanone (1R,3S,9S,10R)-20-(cyclopropylmethyl)-5-(4,6-dimethylpyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-11-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-12-ol (1R,2S,3S,6R,9S,10R)-20-(cyclopropylmethyl)-5-(2-phenylethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(immoethano)-1,5a-epoxynaphtho[1,2-e]indole-10,12-diol